These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32094133)

  • 21. Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics.
    Defraine V; Fauvart M; Michiels J
    Drug Resist Updat; 2018 May; 38():12-26. PubMed ID: 29857815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling protection from antimicrobial agents in biofilms through the formation of persister cells.
    Roberts ME; Stewart PS
    Microbiology (Reading); 2005 Jan; 151(Pt 1):75-80. PubMed ID: 15632427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Putrescine controls the formation of Escherichia coli persister cells tolerant to aminoglycoside netilmicin.
    Tkachenko AG; Kashevarova NM; Karavaeva EA; Shumkov MS
    FEMS Microbiol Lett; 2014 Dec; 361(1):25-33. PubMed ID: 25283595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persister cells and tolerance to antimicrobials.
    Keren I; Kaldalu N; Spoering A; Wang Y; Lewis K
    FEMS Microbiol Lett; 2004 Jan; 230(1):13-8. PubMed ID: 14734160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for persisters in Staphylococcus epidermidis RP62a planktonic cultures and biofilms.
    Shapiro JA; Nguyen VL; Chamberlain NR
    J Med Microbiol; 2011 Jul; 60(Pt 7):950-960. PubMed ID: 21415203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unique transcriptional profile of native persisters in Escherichia coli.
    Matsumoto S; Kawai Y; Miyagawa S; Iwamoto Y; Okuda S; Sánchez-Gorostiaga A; Vicente M; Tsuneda S
    J Biosci Bioeng; 2018 Jan; 125(1):15-22. PubMed ID: 28821380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stationary-phase genes upregulated by polyamines are responsible for the formation of Escherichia coli persister cells tolerant to netilmicin.
    Tkachenko AG; Kashevarova NM; Tyuleneva EA; Shumkov MS
    FEMS Microbiol Lett; 2017 May; 364(9):. PubMed ID: 28431088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persister cells and the riddle of biofilm survival.
    Lewis K
    Biochemistry (Mosc); 2005 Feb; 70(2):267-74. PubMed ID: 15807669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persisters: Methods for Isolation and Identifying Contributing Factors--A Review.
    Rowe SE; Conlon BP; Keren I; Lewis K
    Methods Mol Biol; 2016; 1333():17-28. PubMed ID: 26468096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Genetic Determinant of Persister Cell Formation in Bacterial Pathogens.
    Cameron DR; Shan Y; Zalis EA; Isabella V; Lewis K
    J Bacteriol; 2018 Sep; 200(17):. PubMed ID: 29941425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition.
    Aedo SJ; Orman MA; Brynildsen MP
    BMC Microbiol; 2019 Jun; 19(1):140. PubMed ID: 31234796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli.
    Hofsteenge N; van Nimwegen E; Silander OK
    BMC Microbiol; 2013 Feb; 13():25. PubMed ID: 23379956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of a method to rapidly assay bacterial persister metabolism.
    Orman MA; Brynildsen MP
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4398-409. PubMed ID: 23817376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The formation of persister cells in stationary-phase cultures of Escherichia coli is associated with the aggregation of endogenous proteins.
    Leszczynska D; Matuszewska E; Kuczynska-Wisnik D; Furmanek-Blaszk B; Laskowska E
    PLoS One; 2013; 8(1):e54737. PubMed ID: 23358116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth arrest or drug target inactivity is not sufficient for persister formation in E. coli.
    Xu Y; Cui P; Zhang Y; Zhang W
    Discov Med; 2020; 29(157):103-112. PubMed ID: 33002406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persister eradication: lessons from the world of natural products.
    Keren I; Mulcahy LR; Lewis K
    Methods Enzymol; 2012; 517():387-406. PubMed ID: 23084949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms.
    Lebeaux D; Chauhan A; Létoffé S; Fischer F; de Reuse H; Beloin C; Ghigo JM
    J Infect Dis; 2014 Nov; 210(9):1357-66. PubMed ID: 24837402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study.
    Singh R; Ray P; Das A; Sharma M
    J Med Microbiol; 2009 Aug; 58(Pt 8):1067-1073. PubMed ID: 19528167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analyzing Persister Physiology with Fluorescence-Activated Cell Sorting.
    Orman MA; Henry TC; DeCoste CJ; Brynildsen MP
    Methods Mol Biol; 2016; 1333():83-100. PubMed ID: 26468102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of stationary phase respiration impairs persister formation in E. coli.
    Orman MA; Brynildsen MP
    Nat Commun; 2015 Aug; 6():7983. PubMed ID: 26246187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.